Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-006874
Filing Date
2024-01-26
Accepted
2024-01-26 06:03:59
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm244107-1_s3.htm S-3 597713
2 EXHIBIT 1.2 tm244107d2_ex1-2.htm EX-1.2 230198
3 EXHIBIT 4.1 tm244107d2_ex4-1.htm EX-4.1 325023
4 EXHIBIT 5.1 tm244107d2_ex5-1.htm EX-5.1 33409
5 EXHIBIT 5.2 tm244107d2_ex5-2.htm EX-5.2 6225
6 EXHIBIT 23.2 tm244107d2_ex23-2.htm EX-23.2 2437
7 EX-FILING FEES tm244107d2_ex-filingfees.htm EX-FILING FEES 19588
8 GRAPHIC lg_apreatherapeutics-4c.jpg GRAPHIC 27491
  Complete submission text file 0001104659-24-006874.txt   1252672
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276702 | Film No.: 24564001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)